Officials Lament Barriers to Monkeypox Treatments, Prevention

Officials Lament Barriers to Monkeypox Treatments, Prevention Blame limited supplies and excessive red tape Michael DePeau-Wilson medpagetoday

...

As cases in the U.S. have passed 1,000, infectious disease doctors in New York and Miami are concerned about limited or restricted supply of both post-exposure prophylaxis -- a vaccination protocol known as PEP++ -- and tecovirimat (TPOXX), the antiviral drug for smallpox, to help combat the virus, they said during a press briefing on Thursday organized by the Infectious Diseases Society of America (IDSA)...